Alaunos Therapeutics (TCRT) Q1 2026 Annual Earnings
TCRT·Reported May 15, 2026·After market close
Diluted EPS came in at $-0.59 (+11.9% YoY).
Diluted EPS
$-0.59
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Alaunos Therapeutics's Q1 2026 earnings report.
Alaunos Therapeutics (TCRT) reported Q1 2026 earnings on May 15, 2026 after market close.
Alaunos Therapeutics reported diluted EPS of $-0.59 for Q1 2026.
Compared to the same quarter a year prior, diluted EPS grew 11.9% from $-0.67.
You can read the 10-K periodic report (0001193125-26-134720) directly on SEC EDGAR. The filing index links above go to sec.gov.